James F. Kerwin

3.7k total citations · 1 hit paper
77 papers, 2.8k citations indexed

About

James F. Kerwin is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, James F. Kerwin has authored 77 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 20 papers in Molecular Biology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in James F. Kerwin's work include Nitric Oxide and Endothelin Effects (11 papers), Urinary Bladder and Prostate Research (11 papers) and Hormonal and reproductive studies (10 papers). James F. Kerwin is often cited by papers focused on Nitric Oxide and Endothelin Effects (11 papers), Urinary Bladder and Prostate Research (11 papers) and Hormonal and reproductive studies (10 papers). James F. Kerwin collaborates with scholars based in United States, United Kingdom and France. James F. Kerwin's co-authors include Samuel J. Danishefsky, Paul L. Feldman, Jack R. Lancaster, Michael J. Heller, Ferid Murad, Kunio Ishii, Susumu Kobayashi, Bing Chang, Eric M. Gordon and Marvin J. Miller and has published in prestigious journals such as Science, Journal of the American Chemical Society and Endocrinology.

In The Last Decade

James F. Kerwin

75 papers receiving 2.7k citations

Hit Papers

Nω-nitro-L-arginine: a po... 1990 2026 2002 2014 1990 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James F. Kerwin United States 26 1.1k 997 859 413 359 77 2.8k
Paul L. Feldman United States 25 781 0.7× 831 0.8× 1.1k 1.2× 187 0.5× 452 1.3× 65 3.2k
Donald J. Wolff United States 30 259 0.2× 1.7k 1.7× 905 1.1× 572 1.4× 267 0.7× 50 2.8k
Hidehiko Nakagawa Japan 40 1.2k 1.1× 2.4k 2.4× 778 0.9× 347 0.8× 680 1.9× 170 4.9k
Arnold Stern United States 34 254 0.2× 1.8k 1.8× 807 0.9× 246 0.6× 377 1.1× 115 3.8k
Thomas A. Dix United States 30 554 0.5× 1.6k 1.6× 329 0.4× 480 1.2× 190 0.5× 71 3.2k
Linda J. Roman United States 36 656 0.6× 1.6k 1.7× 2.6k 3.0× 276 0.7× 664 1.8× 108 4.5k
Vasanthy Narayanaswami United States 33 290 0.3× 1.8k 1.8× 854 1.0× 271 0.7× 202 0.6× 85 3.4k
Boris Schmidt Germany 35 843 0.8× 1.6k 1.6× 1.0k 1.2× 550 1.3× 83 0.2× 136 3.9k
Detcho A. Stoyanovsky United States 31 322 0.3× 2.0k 2.0× 777 0.9× 165 0.4× 441 1.2× 75 3.4k
Wolfgang Nastainczyk Germany 36 272 0.2× 2.5k 2.5× 382 0.4× 706 1.7× 327 0.9× 81 4.0k

Countries citing papers authored by James F. Kerwin

Since Specialization
Citations

This map shows the geographic impact of James F. Kerwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James F. Kerwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James F. Kerwin more than expected).

Fields of papers citing papers by James F. Kerwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James F. Kerwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James F. Kerwin. The network helps show where James F. Kerwin may publish in the future.

Co-authorship network of co-authors of James F. Kerwin

This figure shows the co-authorship network connecting the top 25 collaborators of James F. Kerwin. A scholar is included among the top collaborators of James F. Kerwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James F. Kerwin. James F. Kerwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Witte, David G., Michael E. Brune, Ivan Milicic, et al.. (2002). Modeling of Relationships between Pharmacokinetics and Blockade of Agonist-Induced Elevation of Intraurethral Pressure and Mean Arterial Pressure in Conscious Dogs Treated with α1-Adrenoceptor Antagonists. Journal of Pharmacology and Experimental Therapeutics. 300(2). 495–504. 16 indexed citations
2.
Hancock, Arthur A., Steven A. Buckner, Michael E. Brune, et al.. (2002). Preclinical Pharmacology of Fiduxosin, a Novel α1-Adrenoceptor Antagonist with Uroselective Properties. Journal of Pharmacology and Experimental Therapeutics. 300(2). 478–486. 38 indexed citations
3.
Meyer, Michael D., Robert J. Altenbach, Fatima Z. Basha, et al.. (2001). Structure−Activity Studies for a Novel Series of Bicyclic Substituted Hexahydrobenz[e]isoindole α1A Adrenoceptor Antagonists as Potential Agents for the Symptomatic Treatment of Benign Prostatic Hyperplasia. Journal of Medicinal Chemistry. 44(12). 1971–1985. 29 indexed citations
4.
Meyer, Michael D., Robert J. Altenbach, Fatima Z. Basha, et al.. (2000). Structure−Activity Studies for a Novel Series of Tricyclic Substituted Hexahydrobenz[e]isoindole α1A Adrenoceptor Antagonists as Potential Agents for the Symptomatic Treatment of Benign Prostatic Hyperplasia (BPH). Journal of Medicinal Chemistry. 43(8). 1586–1603. 35 indexed citations
5.
Gordon, Eric M. & James F. Kerwin. (1998). Combinatorial chemistry and molecular diversity in drug discovery. Wiley eBooks. 108 indexed citations
6.
Hancock, Arthur A., Michael E. Brune, David G. Witte, et al.. (1998). Actions of A-131701, a Novel, Selective Antagonist for Alpha-1A Compared with Alpha-1B Adrenoceptors on Intraurethral and Blood Pressure Responses in Conscious Dogs and a Pharmacodynamic Assessment of in Vivo Prostatic Selectivity. Journal of Pharmacology and Experimental Therapeutics. 285(2). 628–642. 15 indexed citations
8.
Hancock, Arthur A., C R Vitt, Sheila M. Knepper, et al.. (1996). Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptors.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 885–899. 35 indexed citations
9.
10.
MacKichan, Joanna K., Lene Thomsen, James F. Kerwin, Jean‐Paul Latgé, & Anne Beauvais. (1995). Unsaturated fatty acids are the active molecules of a glucan-synthase-inhibitory fraction isolated from entomophthoralean protoplasts. Microbiology. 141(10). 2757–2762. 2 indexed citations
11.
Kerwin, James F. & Michael J. Heller. (1994). The arginine‐nitric oxide pathway: A target for new drugs. Medicinal Research Reviews. 14(1). 23–74. 185 indexed citations
12.
Raszkiewicz, J L, Donald G. Linville, James F. Kerwin, Frank L. Wagenaar, & Stephen P. Arnerić. (1992). Nitric oxide synthase is critical in mediating basal forebrain regulation of cortical cerebral circulation. Journal of Neuroscience Research. 33(1). 129–135. 56 indexed citations
13.
Ishii, Kunio, James F. Kerwin, & Ferid Murad. (1990). Nω-Nitro-L-arginine: a potent inhibitor of the L-arginine-dependent soluble guanylate cyclase activation pathway in LLC-PK1 cells. Canadian Journal of Physiology and Pharmacology. 68(6). 749–751. 19 indexed citations
14.
Murad, Ferid, Kazuo Ishii, Ulrich Förstermann, et al.. (1990). EDRF is an intracellular second messenger and autacoid to regulate cyclic GMP synthesis in many cells.. PubMed. 24. 441–8. 23 indexed citations
15.
Kerwin, James F., Alex M. Nadzan, Hana Kopecka, et al.. (1989). Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists. Journal of Medicinal Chemistry. 32(4). 739–742. 25 indexed citations
16.
Danishefsky, Samuel J., Susumu Kobayashi, & James F. Kerwin. (1982). Cram rule selectivity in the Lewis acid catalyzed cyclocondensation of chiral aldehydes. A convenient route to chiral systems of biological interest. The Journal of Organic Chemistry. 47(10). 1981–1983. 57 indexed citations
17.
Mattingly, Phillip G., James F. Kerwin, & Marvin J. Miller. (1979). A facile synthesis of substituted N-hydroxy-2-azetidinones. A biogenetic type .beta.-lactam synthesis. Journal of the American Chemical Society. 101(14). 3983–3985. 40 indexed citations
18.
Saunders, Harry L., et al.. (1962). Some Effects of 3:5:3′-Triiodothyropropionic Acid, Methyl Ether in the Rat. Endocrinology. 70(3). 365–374. 1 indexed citations
19.
Kerwin, James F., et al.. (1961). The Synthesis of Some Potential Hypoglycemic Agents1. The Journal of Organic Chemistry. 26(5). 1551–1553. 8 indexed citations
20.
Kerwin, James F., et al.. (1951). Adrenergic Blocking Agents. III. N-(Aryloxyisopropyl)-β-haloethylamines1. Journal of the American Chemical Society. 73(9). 4162–4168. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026